Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Porreca

Showing results (221-230 of 293) with videos related to

Pageof 30
Sort By:
Pain|August 1, 1997
Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptorsT M Laughlin, T W Vanderah, J Lashbrook, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Ontogenic differences in the inhibition of gastric acid secretion by epidermal growth factorR K Rao, H H Chang, S Levenson, et al.
Journal of Medicinal Chemistry|May 7, 1999
delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindoleA Coop, R B Rothman, C Dersch, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 8, 1999
Cyclic enkephalin analogs that are hybrids of DPDPE-related peptides and metenkephalin-Arg-Gly-Leu: prohormone analogs that retain good potency and selectivity for delta opioid receptorsH Bartosz-Bechowski, P Davis, J Slaninova, et al.
Neuroscience Letters|August 9, 1996
Immunofluorescence analysis of antisense oligodeoxynucleotide-mediated 'knock-down' of the mouse delta opioid receptor in vitro and in vivoJ Lai, M Riedl, L S Stone, et al.
Journal of Medicinal Chemistry|December 16, 1997
Cyclic enkephalin analogues with exceptional potency and selectivity for delta-opioid receptorsV J Hruby, H Bartosz-Bechowski, P Davis, et al.
Journal of Medicinal Chemistry|December 9, 1994
Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13)H I Mosberg, J R Omnaas, A Lomize, et al.
Neuroscience|December 12, 2003
Mouse strains that lack spinal dynorphin upregulation after peripheral nerve injury do not develop neuropathic painL R Gardell, M Ibrahim, R Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in ratsT J Martin, S A Kim, D G Cannon, et al.
Neuroscience|May 3, 2006
Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitizationL P Vera-Portocarrero, E-T Zhang, M H Ossipov, et al.
Pageof 30

Showing results (221-230 of 293) with videos related to

Sort By:
Pageof 30
Pain|August 1, 1997
Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptorsT M Laughlin, T W Vanderah, J Lashbrook, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Ontogenic differences in the inhibition of gastric acid secretion by epidermal growth factorR K Rao, H H Chang, S Levenson, et al.
Journal of Medicinal Chemistry|May 7, 1999
delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindoleA Coop, R B Rothman, C Dersch, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 8, 1999
Cyclic enkephalin analogs that are hybrids of DPDPE-related peptides and metenkephalin-Arg-Gly-Leu: prohormone analogs that retain good potency and selectivity for delta opioid receptorsH Bartosz-Bechowski, P Davis, J Slaninova, et al.
Neuroscience Letters|August 9, 1996
Immunofluorescence analysis of antisense oligodeoxynucleotide-mediated 'knock-down' of the mouse delta opioid receptor in vitro and in vivoJ Lai, M Riedl, L S Stone, et al.
Journal of Medicinal Chemistry|December 16, 1997
Cyclic enkephalin analogues with exceptional potency and selectivity for delta-opioid receptorsV J Hruby, H Bartosz-Bechowski, P Davis, et al.
Journal of Medicinal Chemistry|December 9, 1994
Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13)H I Mosberg, J R Omnaas, A Lomize, et al.
Neuroscience|December 12, 2003
Mouse strains that lack spinal dynorphin upregulation after peripheral nerve injury do not develop neuropathic painL R Gardell, M Ibrahim, R Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in ratsT J Martin, S A Kim, D G Cannon, et al.
Neuroscience|May 3, 2006
Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitizationL P Vera-Portocarrero, E-T Zhang, M H Ossipov, et al.
Pageof 30